世界のシラミ治療市場は、予測期間中に約6.26 %のCAGRで推移し、2022年から2026年の間に1億2,897万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。
本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。市場は、シラミの蔓延の増加、医療費の増加、およびシラミ治療製品の容易な入手可能性によって推進されています。 さらに、シラミの蔓延の増加は、市場の成長も後押しすると予想されます。
本調査では、今後数年間におけるシラミ治療市場の成長を促進する主な理由の1つとして、子供の人口増加を挙げています。また、標的療法の研究開発への投資の増加や新しい治療法の出現は、市場の大きな需要につながるでしょう。
Technavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要なシラミ治療市場ベンダーの詳細な分析を提供します
この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。
TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。Technavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。
目次
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Distribution Channel
5.1 Market segments
Exhibit 24: Chart on Distribution Channel - Market share 2021-2026 (%)
Exhibit 25: Data Table on Distribution Channel - Market share 2021-2026 (%)
5.2 Comparison by Distribution Channel
Exhibit 26: Chart on Comparison by Distribution Channel
Exhibit 27: Data Table on Comparison by Distribution Channel
5.3 Hospitals and clinics - Market size and forecast 2021-2026
Exhibit 28: Chart on Hospitals and clinics - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Hospitals and clinics - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Hospitals and clinics - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Hospitals and clinics - Year-over-year growth 2021-2026 (%)
5.4 Online - Market size and forecast 2021-2026
Exhibit 32: Chart on Online - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Online - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Online - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Online - Year-over-year growth 2021-2026 (%)
5.5 Retail pharmacies - Market size and forecast 2021-2026
Exhibit 36: Chart on Retail pharmacies - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Retail pharmacies - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Retail pharmacies - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Retail pharmacies - Year-over-year growth 2021-2026 (%)
5.6 Market opportunity by Distribution Channel
Exhibit 40: Market opportunity by Distribution Channel ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 44: Chart on Geographic comparison
Exhibit 45: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 UK - Market size and forecast 2021-2026
Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.9 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.10 Germany - Market size and forecast 2021-2026
Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.11 Japan - Market size and forecast 2021-2026
Exhibit 78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 82: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 83: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 85: Overview on factors of disruption
9.4 Industry risks
Exhibit 86: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 87: Vendors covered
10.2 Market positioning of vendors
Exhibit 88: Matrix on vendor position and classification
10.3 Alliance Pharma Plc
Exhibit 89: Alliance Pharma Plc - Overview
Exhibit 90: Alliance Pharma Plc - Business segments
Exhibit 91: Alliance Pharma Plc - Key offerings
Exhibit 92: Alliance Pharma Plc - Segment focus
10.4 Arbor Pharmaceuticals LLC
Exhibit 93: Arbor Pharmaceuticals LLC - Overview
Exhibit 94: Arbor Pharmaceuticals LLC - Product / Service
Exhibit 95: Arbor Pharmaceuticals LLC - Key offerings
10.5 Bayer AG
Exhibit 96: Bayer AG - Overview
Exhibit 97: Bayer AG - Business segments
Exhibit 98: Bayer AG - Key news
Exhibit 99: Bayer AG - Key offerings
Exhibit 100: Bayer AG - Segment focus
10.6 Elanco Animal Health Inc.
Exhibit 101: Elanco Animal Health Inc. - Overview
Exhibit 102: Elanco Animal Health Inc. - Product / Service
Exhibit 103: Elanco Animal Health Inc. - Key offerings
10.7 Fleming Medical Ltd.
Exhibit 104: Fleming Medical Ltd. - Overview
Exhibit 105: Fleming Medical Ltd. - Product / Service
Exhibit 106: Fleming Medical Ltd. - Key offerings
10.8 Merck and Co. Inc.
Exhibit 107: Merck and Co. Inc. - Overview
Exhibit 108: Merck and Co. Inc. - Business segments
Exhibit 109: Merck and Co. Inc. - Key news
Exhibit 110: Merck and Co. Inc. - Key offerings
Exhibit 111: Merck and Co. Inc. - Segment focus
10.9 PARAPRO LLC
Exhibit 112: PARAPRO LLC - Overview
Exhibit 113: PARAPRO LLC - Product / Service
Exhibit 114: PARAPRO LLC - Key offerings
10.10 Prestige Consumer Healthcare Inc.
Exhibit 115: Prestige Consumer Healthcare Inc. - Overview
Exhibit 116: Prestige Consumer Healthcare Inc. - Business segments
Exhibit 117: Prestige Consumer Healthcare Inc. - Key offerings
Exhibit 118: Prestige Consumer Healthcare Inc. - Segment focus
10.11 Teva Pharmaceutical Industries Ltd.
Exhibit 119: Teva Pharmaceutical Industries Ltd. - Overview
Exhibit 120: Teva Pharmaceutical Industries Ltd. - Business segments
Exhibit 121: Teva Pharmaceutical Industries Ltd. - Key news
Exhibit 122: Teva Pharmaceutical Industries Ltd. - Key offerings
Exhibit 123: Teva Pharmaceutical Industries Ltd. - Segment focus
10.12 Thornton Ross Ltd.
Exhibit 124: Thornton Ross Ltd. - Overview
Exhibit 125: Thornton Ross Ltd. - Product / Service
Exhibit 126: Thornton Ross Ltd. - Key offerings
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 127: Inclusions checklist
Exhibit 128: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 129: Currency conversion rates for US$
11.4 Research methodology
Exhibit 130: Research methodology
Exhibit 131: Validation techniques employed for market sizing
Exhibit 132: Information sources
11.5 List of abbreviations
Exhibit 133: List of abbreviations
